{"id":8674,"date":"2017-11-10T13:54:11","date_gmt":"2017-11-10T13:54:11","guid":{"rendered":"http:\/\/fefac.cat\/empresarial\/?p=8674"},"modified":"2017-11-10T13:54:11","modified_gmt":"2017-11-10T13:54:11","slug":"lleuger-augment-del-consum-dantidepressius-i-anti","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/","title":{"rendered":"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics"},"content":{"rendered":"<p>L&rsquo;informe<a href=\"https:\/\/www.aspb.cat\/documents\/informe-salut-2016\/\"> &lsquo;La Salut a Barcelona&rsquo; <\/a>de l&rsquo;any 2016, elaborat per l&rsquo;Ag&egrave;ncia de Salut P&uacute;blica del Consorci Sanitari de Barcelona, ofereix dades sobre el consum de f&agrave;rmacs de la poblaci&oacute; barcelonina. Els dos grups farmacol&ograve;gics que presenten un major consum en envasos i en import van ser el del sistema nervi&oacute;s i sistema cardiovascular, amb un 27,4% i un 26,9% respectivament sobre el total dels envasos de les especialitats farmac&egrave;utiques.<\/p>\n<p>El document inclou dades evolutives de les dosis receptades per 1.000 habitants i dia, del per&iacute;ode 2011-2016 dels subgrups farmacol&ograve;gics del sistema nervi&oacute;s m&eacute;s prevalents en salut mental: ansiol&iacute;tics, hipn&ograve;tics i sedants, antidepressius, i antipsic&ograve;tics (taula 11).<\/p>\n<p>El consum d&rsquo;ansiol&iacute;tics i hipn&ograve;tics i sedants ha baixat, sobretot en la poblaci&oacute; m&eacute;s consumidora d&rsquo;aquests f&agrave;rmacs que &eacute;s la franja d&rsquo;edat de majors de 44 anys. En canvi, l&rsquo;&uacute;s dels antidepressius i antipsic&ograve;tics ha augmentat.<\/p>\n<p>Cal destacar que el consum d&rsquo;aquests quatre grups de f&agrave;rmacs &eacute;s elevat en la poblaci&oacute; de majors de 75 anys, amb major freq&uuml;&egrave;ncia en dones. Tamb&eacute; s&rsquo;observa que hi ha difer&egrave;ncies en funci&oacute; dels districtes de Barcelona (taula 12).<\/p>\n<p><img decoding=\"async\" alt=\"\" data-src=\"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg\" style=\"width: 600px; height: 602px;\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" \/><\/p>\n<p><img decoding=\"async\" alt=\"\" data-src=\"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/Consum%20medicaments%20sistema%20nervios%20districte%20sexe.JPG\" style=\"width: 580px; height: 403px;\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" \/><\/p>\n<p>L&rsquo;informe anual &lsquo;La Salut a Barcelona&rsquo; presenta l&rsquo;estat de salut de la ciutadania, en el marc dels determinants de l&rsquo;entorn socioecon&ograve;mic i de l&rsquo;entorn f&iacute;sic. L&rsquo;Ag&egrave;ncia de Salut P&uacute;blica de Barcelona gestiona els centres i serveis de salut p&uacute;blica de Barcelona per enc&agrave;rrec de l&rsquo;Ajuntament i la Generalitat de Catalunya. Desplega la protecci&oacute; i vigil&agrave;ncia de la salut, com tamb&eacute; tasques de prevenci&oacute; i promoci&oacute;, i es constitueix en autoritat sanit&agrave;ria a la ciutat.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&rsquo;informe &lsquo;La Salut a Barcelona&rsquo; de l&rsquo;any 2016, elaborat per l&rsquo;Ag&egrave;ncia de Salut P&uacute;blica del Consorci Sanitari de Barcelona, ofereix dades sobre el consum de f&agrave;rmacs de la poblaci&oacute; barcelonina. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[18,11,12,13,14,15],"tags":[724,1633,1634,1635],"class_list":["post-8674","post","type-post","status-publish","format-standard","hentry","category-general","category-fefac","category-afb","category-afet","category-afell","category-agfe","tag-antidepressius","tag-ansiolitics","tag-antipsicotics","tag-hipnotics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics - FEFAC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics - FEFAC\" \/>\n<meta property=\"og:description\" content=\"L&rsquo;informe &lsquo;La Salut a Barcelona&rsquo; de l&rsquo;any 2016, elaborat per l&rsquo;Ag&egrave;ncia de Salut P&uacute;blica del Consorci Sanitari de Barcelona, ofereix dades sobre el consum de f&agrave;rmacs de la poblaci&oacute; barcelonina. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2017-11-10T13:54:11+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg\" \/>\n<meta name=\"author\" content=\"qabh859\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"qabh859\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/\"},\"author\":{\"name\":\"qabh859\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"headline\":\"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics\",\"datePublished\":\"2017-11-10T13:54:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/\"},\"wordCount\":369,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.fefac.cat\\\/intranet\\\/noticies\\\/_userfiles\\\/images\\\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg\",\"keywords\":[\"antidepressius\",\"ansiol\u00edtics\",\"antipsic\u00f2tics\",\"hipn\u00f2tics\"],\"articleSection\":[\"General\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/\",\"name\":\"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.fefac.cat\\\/intranet\\\/noticies\\\/_userfiles\\\/images\\\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg\",\"datePublished\":\"2017-11-10T13:54:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.fefac.cat\\\/intranet\\\/noticies\\\/_userfiles\\\/images\\\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg\",\"contentUrl\":\"http:\\\/\\\/www.fefac.cat\\\/intranet\\\/noticies\\\/_userfiles\\\/images\\\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/lleuger-augment-del-consum-dantidepressius-i-anti\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\",\"name\":\"qabh859\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/qabh859\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics - FEFAC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/","og_locale":"ca_ES","og_type":"article","og_title":"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics - FEFAC","og_description":"L&rsquo;informe &lsquo;La Salut a Barcelona&rsquo; de l&rsquo;any 2016, elaborat per l&rsquo;Ag&egrave;ncia de Salut P&uacute;blica del Consorci Sanitari de Barcelona, ofereix dades sobre el consum de f&agrave;rmacs de la poblaci&oacute; barcelonina. [&hellip;]","og_url":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/","og_site_name":"FEFAC","article_published_time":"2017-11-10T13:54:11+00:00","og_image":[{"url":"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg","type":"","width":"","height":""}],"author":"qabh859","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"qabh859","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/"},"author":{"name":"qabh859","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"headline":"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics","datePublished":"2017-11-10T13:54:11+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/"},"wordCount":369,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/#primaryimage"},"thumbnailUrl":"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg","keywords":["antidepressius","ansiol\u00edtics","antipsic\u00f2tics","hipn\u00f2tics"],"articleSection":["General","FEFAC","AFB","AFET","AFELL","AGFE"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/","url":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/","name":"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/#primaryimage"},"thumbnailUrl":"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg","datePublished":"2017-11-10T13:54:11+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/#primaryimage","url":"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg","contentUrl":"http:\/\/www.fefac.cat\/intranet\/noticies\/_userfiles\/images\/consum%20f%C3%A0rmacs%20sistema%20nervi%C3%B3s.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/lleuger-augment-del-consum-dantidepressius-i-anti\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Lleuger augment del consum d\u2019antidepressius i antipsic\u00f2tics i baixada dels ansiol\u00edtics i hipn\u00f2tics"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7","name":"qabh859","url":"https:\/\/fefac.cat\/empresarial\/author\/qabh859\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/8674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=8674"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/8674\/revisions"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=8674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=8674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=8674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}